With the analysis among 1,152 patents, we discovered top 311 key players by total patent application. Regeneron Pharmaceuticals, Inc., Genentech, Inc., Merrimack Pharmaceuticals, Inc. are dominant in this area. They take 11.98% of the total patent filing.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 56
California, United States
Patent: 56
Merrimack Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 26
Massachusetts, United States
Patent: 24
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 16
Hessen, Germany
Patent: 16
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 15
Pennsylvania, United States
Patent: 14
California, United States
Patent: 13
F. Hoffmann-La Roche Ltd.
With the analysis among 15 patents, we discovered top 3 start-ups by total patent application.
Institut National de la Santé et de la Recherche Médicale
Kent, United Kingdom
Patent: 3
Gyeonggi-do, South Korea
Patent: 1
With the analysis among related 135 patents applied in the last 5 years. We discover 53 most active companies in this area. The fast-growing Janssen Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc., Numab Therapeutics AG take 25.93% of patent filing during this period.
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 16
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 11
ZURICH, Switzerland
Patent: 8
New Jersey, United States
Patent: 6
Regents of the University of California
California, United States
Patent: 6
Shanghai JMT Biological Technology Co Ltd
Shanghai Shi, China
Patent: 6
Centre National De La Recherche Scientif
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
With the analysis among related 135 patents in last 5 years, we discover 34 new entrants. Janssen Pharmaceuticals, Inc., Numab Therapeutics AG, Eutilex Co., Ltd. are the most active new entrants in this area.
Janssen Pharmaceuticals, Inc.
New Jersey, United States
Patent: 16
ZURICH, Switzerland
Patent: 8
New Jersey, United States
Patent: 6
Shanghai JMT Biological Technology Co Ltd
Shanghai Shi, China
Patent: 6
The Governors of the University of Alberta
Renocell Biotechnology Co., Ltd.
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 4
With the analysis among 296 patents, we discovered top 60 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, Centre Hospitalier Universitaire de Montpellier, Ghent University are dominant in this area. They take 32.43% of the total patent filing.
Vlaams Instituut voor Biotechnologie - Flanders Institute
Centre Hospitalier Universitaire de Montpellier
Oost-Vlaanderen, Belgium
Patent: 23
La Jolla Cancer Research Foundation
California, United States
Patent: 15
New York, United States
Patent: 9
Institut Gustave Roussy EURL
Arizona, United States
Patent: 8
Niedersachsen, Germany
Patent: 8
United Arab Emirates University
United Arab Emirates
Patent: 7
New Jersey, United States
Patent: 5